Huang Xiaori, Wang Lei, Liu Wei, Li Fei
Department of Respiratory Medicine, People's Hospital of Rizhao, Rizhao, Shandong 276826, P.R. China.
Oncol Lett. 2019 Mar;17(3):3425-3431. doi: 10.3892/ol.2019.9954. Epub 2019 Jan 21.
Increasing number of microRNAs (miRNAs) have been reported to play an important role in the development and progression of non-small cell lung cancer (NSCLC). In particular, microRNA-497-5p (miR-497-5p) has been proposed as a tumor suppressor miRNA in human cancers. However, the role of miR-497-5p and its potential molecular mechanism associated with NSCLC are less studied. Therefore, the role of miR-497-5p in the pathogenesis of NSCLC was investigated. In the present study, the expression of miR-497-5p was significantly downregulated in NSCLC. Moreover, overexpression of miR-497-5p inhibited the proliferation and invasion of NSCLC cells by suppressing FGF2. In addition, FGF2 was a downstream target of miR-497-5p in NSCLC. FGF2 was upregulated in NSCLC promoting cell proliferation and invasion. Overexpression of FGF2 impaired the inhibitory effect of miR-497-5p in NSCLC. Taken together, these results demonstrate that miR-497-5p is a tumor suppressor miRNA and demonstrate its potential for future use in the treatment of human NSCLC.
越来越多的微小RNA(miRNA)被报道在非小细胞肺癌(NSCLC)的发生和发展中起重要作用。特别是,微小RNA-497-5p(miR-497-5p)已被认为是人类癌症中的一种肿瘤抑制性miRNA。然而,miR-497-5p在NSCLC中的作用及其潜在分子机制的研究较少。因此,本研究探讨了miR-497-5p在NSCLC发病机制中的作用。在本研究中,miR-497-5p在NSCLC中的表达显著下调。此外,miR-497-5p的过表达通过抑制FGF2抑制NSCLC细胞的增殖和侵袭。此外,FGF2是NSCLC中miR-497-5p的下游靶点。FGF2在NSCLC中上调,促进细胞增殖和侵袭。FGF2的过表达削弱了miR-497-5p对NSCLC的抑制作用。综上所述,这些结果表明miR-497-5p是一种肿瘤抑制性miRNA,并显示了其在未来治疗人类NSCLC中的潜力。